Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fermentation broth

ABSTRACT: fermentation broth Raw sequence reads

PROVIDER: PRJNA880801 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21614949_1.fastq.gz	Fastqsanger.gz
	SRR21614949_2.fastq.gz	Fastqsanger.gz
	SRR21614950_1.fastq.gz	Fastqsanger.gz
	SRR21614950_2.fastq.gz	Fastqsanger.gz
	SRR21614951_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

fermentation broth

Project description:fermentation broth Raw sequence reads

| PRJNA1063056 | ENA

Fermentation broth

Project description:Fermentation broth Raw sequence reads

| PRJNA880797 | ENA

Fermentation broth

Project description:Fermentation broth Raw sequence reads

| PRJNA991268 | ENA

fermentation broth

Project description:fermentation broth Raw sequence reads

| PRJNA880785 | ENA

fermentation broth

Project description:rice fermentation broth Raw sequence reads

| PRJNA870658 | ENA

Bacteria in fermentation broth

Project description:Bacteria in fermentation broth Genome sequencing and assembly

| PRJNA891622 | ENA

Proteomics analysis of fermentation broth under different nitrogen sources in Starmerella bombicola

Project description:S. bombicola was fermented under two different nitrogen sources (yeast extract or ammonium sulfate). The fermentation broth after 7 days’ cultivation was taken for extracellular proteins analysis.

2022-02-16 | PXD023214 | Pride

Dilute-and-Shoot Analysis of Therapeutic Monoclonal Antibody Variants in Fermentation Broth: A Method Capability Study

Project description:Monoclonal antibodies (mAbs) are widely applied as highly specific and efficient thera-peutic agents for various diseases, including cancer, inflammatory and autoimmune diseases. As protein production in cellular systems inherently generates a multitude of molecular variants, manufacturing of mAbs requires stringent control in order to ensure safety and efficacy of the drug. Moreover, monitoring of mAb variants in the course of the fermentation process may allow instant tuning of process parameters to maintain optimal cell culture conditions. Here, we describe a fast and robust workflow for the characterization of mAb variants in fermentation broth. Sample preparation is minimal in that the fermentation broth is shortly centrifuged before dilution and HPLC-MS analysis in a short 15-min gradient run. In a single analysis, N-glycosylation and truncation variants of the expressed mAb can be identified at the intact protein level. The molecular attributes of the expressed therapeutic protein may thus be continuously monitored to ensure the desired product profile. Simultaneously, absolute quantification of mAb content in fermentation broth yielded concentrations of 67 and 2578 ng.mL-1 at the beginning and end of fermentation, respectively. The whole workflow features excellent robustness as well as retention time and peak area stability of 0.3% and 4.9% RSD. Additional enzymatic removal of N-glycans enables determination of mAb glycation levels, which are subsequently considered in relative N-glycoform quantification to correct for isobaric galactosylation. Application of the described workflow in an industrial environment may therefore substantially enhance in-process control in mAb production as well as targeted biosimilar development.

2019-11-12 | PXD011017 | Pride

Microbial sequencing of traditional Chinese medicine fermentation broth

Project description:Microbial sequencing of traditional Chinese medicine fermentation broth

| PRJEB35333 | ENA

Microbial sequencing of traditional Chinese medicine fermentation broth

Project description:Microbial sequencing of traditional Chinese medicine fermentation broth Targeted loci environmental

| PRJNA557812 | ENA